Literature DB >> 8653189

Indirect cost in economic evaluation: the opportunity cost of unpaid inputs.

J Posnett1, S Jan.   

Abstract

Unpaid time represents a potentially significant input into the health production function. The paper sets out the basis for valuation of time inputs consistent with the notion of opportunity cost. Such analysis requires consideration of whether time displaced in the production of health involves lost work or lost leisure. Furthermore, because valuation of opportunity cost requires the consistent treatment of costs and benefits, the study also considers the valuation of outputs. The basis for valuing the shadow price of work time is examined by firstly assuming perfect competition. The analysis then considers the presence of monopoly and monopsony in product markets and income and sales taxes. The basis for valuing the shadow price of leisure ("leisure' being all uses of time except paid employment) is restricted to an examination of methods previously used to value unpaid housework. The two methods examined are the replacement cost and the opportunity cost method. As the methods are not equivalent, the circumstances where each is appropriate vary depending on whether the output lost in producing health is replaced. Although not set out as the primary focus of the paper, the issues surrounding the valuation of outputs generated by non-market and quasi-market activity are examined. In particular, where activities such as informal care result in indirect utility to the carers (and patients) themselves, it is likely the full market wage provides a lower bound estimate of the value of marginal benefit. Finally the paper provides a practical approach to examining opportunity cost of unpaid inputs consistent with the concepts set out in preceding sections.

Entities:  

Mesh:

Year:  1996        PMID: 8653189     DOI: 10.1002/(SICI)1099-1050(199601)5:1<13::AID-HEC182>3.0.CO;2-J

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  54 in total

1.  Household income losses associated with ischaemic heart disease for US employees.

Authors:  J Herrin; C B Cangialose; S J Boccuzzi; W S Weintraub; D J Ballard
Journal:  Pharmacoeconomics       Date:  2000-03       Impact factor: 4.981

Review 2.  Handling uncertainty in cost-effectiveness models.

Authors:  A H Briggs
Journal:  Pharmacoeconomics       Date:  2000-05       Impact factor: 4.981

Review 3.  Economic Notes: opportunity cost.

Authors:  S Palmer; J Raftery
Journal:  BMJ       Date:  1999-06-05

4.  Measuring the time costs of exercise: a proposed measuring method and a pilot study.

Authors:  Lars Axel Hagberg; Lars Lindholm
Journal:  Cost Eff Resour Alloc       Date:  2010-05-11

Review 5.  Economic valuation of informal care. An overview of methods and applications.

Authors:  Bernard van den Berg; Werner B F Brouwer; Marc A Koopmanschap
Journal:  Eur J Health Econ       Date:  2004-02

6.  Workload, time and costs of the informal cares in patients with tele-monitoring of pacemakers: the PONIENTE study.

Authors:  Antonio López-Villegas; Daniel Catalán-Matamoros; Emilio Robles-Musso; Salvador Peiró
Journal:  Clin Res Cardiol       Date:  2015-09-30       Impact factor: 5.460

7.  The impact of time cost of physical exercise on health outcomes by older adults: the DR's EXTRA Study.

Authors:  Virpi Kuvaja-Köllner; Hannu Valtonen; Pirjo Komulainen; Maija Hassinen; Rainer Rauramaa
Journal:  Eur J Health Econ       Date:  2012-04-25

8.  Economic valuation and determinants of informal care to people with Alzheimer's disease.

Authors:  Luz María Peña-Longobardo; Juan Oliva-Moreno
Journal:  Eur J Health Econ       Date:  2014-05-07

9.  Indirect costs in ambulatory patients with HIV/AIDS in Spain: a pilot study.

Authors:  Juan Oliva; César Roa; Juan del Llano
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

10.  Subcutaneous vs intravenous administration of immunoglobulin in chronic inflammatory demyelinating polyneuropathy: an Italian cost-minimization analysis.

Authors:  Carlo Lazzaro; Leonardo Lopiano; Dario Cocito
Journal:  Neurol Sci       Date:  2014-01-28       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.